Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2023
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached the Investor Presentation on the unaudited financial results for the quarter / nine months ended on December 31, 2022.
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on the unaudited financial results for the quarter / half year ended on September 30, 2022
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on the unaudited financial results for the quarter ended on June 30, 2022
Investor Presentation Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation
Investor Presentation CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on the unaudited financial results for the quarter ended on December 31, 2021
Investor Presentation CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on unaudited financial results for the quarter / half year ended September 30, 2021
Investor Presentation Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Update on Investors Presentation